Percutaneous Versus Open Plate Fixation of Diaphyseal Clavicle Fractures

Sponsor
University of Utah (Other)
Overall Status
Completed
CT.gov ID
NCT01405703
Collaborator
(none)
35
1
46
0.8

Study Details

Study Description

Brief Summary

This is a prospective, level II evidence comparison between two cohorts. This study is designed to compare the percutaneous versus open approach for plate fixation of diaphyseal clavicle fractures. This study includes questionnaires and measurements that will collect data on incision-related numbness, union rates, overall outcomes, complication rates of the two methods, infection rates, and overall satisfaction. The surgical procedure, all radiographs and follow-up visits to a minimum of one year are the principle investigators (PI's) standard of care for this injury. Measurements and questionnaires are related to the study.

Condition or Disease Intervention/Treatment Phase
  • Other: xrays

Study Design

Study Type:
Observational
Actual Enrollment :
35 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Percutaneous Versus Open Plate Fixation of Diaphyseal Clavicle Fractures
Study Start Date :
Jul 1, 2011
Actual Primary Completion Date :
May 1, 2015
Actual Study Completion Date :
May 1, 2015

Arms and Interventions

Arm Intervention/Treatment
percuataneous plate fixation

an approach with three small longitudinal incisions

Other: xrays
xrays from 2 week postop to 5 year postop

open plate fixation

large transverse incision

Other: xrays
xrays from 2 week postop to 5 year postop

Outcome Measures

Primary Outcome Measures

  1. Functional outcome as measured by Constant Shoulder Score and Disabilities of the Arm, Shoulder and Hand (DASH) score [1+ year post-op]

    The primary outcome measure for this study will be incision related numbness, based on clinical examination and the use of our skin numbness map. Our null hypothesis is that there will be no difference in incision related numbness between the two groups: percutaneous versus open approach. Our primary objective is to disprove this hypothesis, predicting that the percutaneously treated group will have less incisional numbness.

Secondary Outcome Measures

  1. Incision numbness at surgical site. [2 wks, 6 wks, 3 mths, 6mnths and 1+ year post-op]

    Our secondary outcome measures will be union, malunion, and nonunion rates between these two methods, as well as infection rates and functional and satisfaction outcomes based on subjective questioning and the DASH and Constant shoulder score questionnaires. Our null hypothesis for these secondary outcomes is that there will be no difference between the two treatment groups.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years of age or older

  • displaced (i.e., no cortical contact of fracture ends on two xray view) diaphyseal clavicle fracture

  • fracture pattern amenable to plate fixation

  • neurologic injury requiring open reduction

  • open clavicle fracture

  • clavicle nonunion (defined as an absence of radiographic bony union in the presence of neurologic, cosmetic, or functional complaints at six months duration

  • symptomatic malunion (defined as a healed, but shortened or angulated fracture in the presence of neurologic, cosmetic, or functional complaints)

  • clavicle fracture associated with a scapular of humeral fracture (floating shoulder)

Exclusion Criteria:
  • a nondisplaced or minimally displaced closed, neurovascularly intact clavicle fracture

  • fracture of the medial or lateral end of the clavicle

  • pathological fracture

  • patient is unable to medically tolerate general anesthesia

  • patient is unable to provide informed consent or comply with completing questionnaires

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Utah Orthopedic Center Salt Lake City Utah United States 84121

Sponsors and Collaborators

  • University of Utah

Investigators

  • Principal Investigator: Erik Kubiak, MD, University of Utah
  • Principal Investigator: Thomas Christensen, MD, University of Utah

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eric Kubiak, M.D., University of Utah
ClinicalTrials.gov Identifier:
NCT01405703
Other Study ID Numbers:
  • 36814
First Posted:
Jul 29, 2011
Last Update Posted:
Jul 9, 2015
Last Verified:
Jul 1, 2015

Study Results

No Results Posted as of Jul 9, 2015